Novavax Inc. (NVAX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Novavax Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$10.32
+2.99% today
Market cap
$1.7B
Overall quality
—
Kronos AI 30-day
−11.9%
2 of 8 simulated paths end higher
Novavax Inc. (NVAX) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $1.7B. It trades at $10.32, up 2.99% today. 4 analysts' average target of $10.75 implies +4.2% from today's price. Kronos AI's 30-day forecast is −11.9% (2 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $10.75 |
| Low – high | $8.00 – $18.00 |
| Analysts | 4 |
| Upside to average | +4.2% |
Kronos AI 30-day forecast
| Expected close | $8.83 (−11.9%) |
| Likely range | −15.8% … +3.8% |
| As of | 2026-10-27 |
2 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.